An awareness campaign is raising a concern and driving change to make the greatest impact on lung cancer, ensuring a world where none dies of lung cancer.
FREMONT, CA: The nation's leading lung cancer-focused non-profit organization, LUNGevity Foundation has unveiled the #ChangeLungCancer social media campaign. The foundation is proud to provide a unique passage for lung cancer advocates to get involved during November, the Lung Cancer Awareness Month, through this social media campaign. LUNGevity empowers patients to be active decision-makers throughout the treatment process through the foundation's extensive educational resources, online peer-to-peer support, and in-person survivorship programs. The foundation provides a community of empowerment, support, and hope as well as more than 80 grassroots awareness and fundraising events held from coast to coast each year.
#ChangeLungCancer social media campaign's main aim is to raise awareness of lung cancer and help inspire others to help drive change through a variety of downloadable signs with powerful messages. People participating in the campaign and supporting the cause simply have to take a selfie holding one of the several #ChangeLungCancer signs and share it on social media with their reason for changing lung cancer. The foundation tries to equip individuals with the tools they need to help spread awareness about lung cancer during the month. LUNGevity Foundation aims to drive change through this campaign, enabling patients to fight against the deadly disease.
LUNGevity is the nation's pioneering lung cancer organization investing in lifesaving, translational research, and providing support services and education for patients and caregivers. The company aims to expedite research to patients, empower patients to be active participants in their treatment decisions, and eliminate barriers that patients face in accessing the right treatment. LUNGevity Foundation is aims at making an immediate impact on enhancing the quality of life and survivorship of people with lung cancer by expediting research into early detection and more effective treatments.
